UBS ASSET MANAGEMENT AMERICAS INC – Bio-Rad Laboratories, Inc. Transaction History
UBS ASSET MANAGEMENT AMERICAS INC portfolio value:
$164.36M
portfolio value
UBS ASSET MANAGEMENT AMERICAS INC quarter portfolio value change:
-15.73%
quarter
Bio-Rad Laboratories, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +5.13% | 19.24K shares | -21.15M | $417.14 | 394.03K |
Q2 2022 | share | Increase | +8.20% | 28.41K shares | -9.56M | $495 | 374.78K |
Q1 2022 | share | Increase | +0.73% | 2.49K shares | -64.73M | $563.23 | 346.37K |
Q4 2021 | share | Decrease | -3.84% | -13.72K shares | -6.92M | $758.65 | 343.87K |
Q3 2021 | share | Decrease | -3.40% | -12.57K shares | 28.25M | $745.95 | 357.6K |
Q2 2021 | share | Decrease | -3.30% | -12.62K shares | 19.85M | $644.29 | 370.17K |
Q1 2021 | share | Decrease | -23.98% | -120.75K shares | -74.89M | $571.17 | 382.8K |
Q4 2020 | share | Increase | +30.41% | 117.41K shares | 94.50M | $582.94 | 503.55K |
Q3 2020 | share | Decrease | -6.41% | -26.42K shares | 12.76M | $515.46 | 386.14K |
Q2 2020 | share | Increase | +12.64% | 46.28K shares | 57.86M | $451.49 | 412.57K |
Q1 2020 | share | Decrease | -17.01% | -75.05K shares | -34.90M | $350.56 | 366.28K |
Q4 2019 | share | Increase | +5.46% | 22.83K shares | 24.05M | $370.03 | 441.34K |
Q3 2019 | share | Increase | +5.36% | 21.28K shares | 15.08M | $332.74 | 418.50K |
Q2 2019 | share | Increase | +2.72% | 10.53K shares | 5.96M | $312.59 | 397.22K |
Q1 2019 | share | Decrease | -6.78% | -28.12K shares | 21.87M | $305.68 | 386.68K |
Q4 2018 | share | Increase | +62.84% | 160.07K shares | 16.59M | $232.22 | 414.81K |
Q3 2018 | share | Decrease | -7.09% | -19.44K shares | 618.83K | $312.99 | 254.73K |
Q2 2018 | share | Decrease | -2.24% | -6.29K shares | 8.97M | $288.54 | 274.17K |
Q1 2018 | share | Decrease | -21.96% | -78.93K shares | -15.63M | $250.08 | 280.47K |
Q4 2017 | share | Decrease | -12.62% | -51.88K shares | -5.61M | $238.67 | 359.41K |
Q3 2017 | share | Decrease | -3.71% | -15.82K shares | -5.26M | $222.22 | 411.29K |
Q2 2017 | share | Decrease | -2.22% | -9.70K shares | 9.58M | $226.31 | 427.12K |
Q1 2017 | share | Decrease | -6.42% | -29.95K shares | 1.99M | $199.34 | 436.83K |
Q4 2016 | share | Increase | +9.04% | 38.71K shares | 14.96M | $182.28 | 466.78K |
Q3 2016 | share | Decrease | -4.63% | -20.76K shares | 5.93M | $163.81 | 428.07K |
Q2 2016 | share | Increase | +7.96% | 33.07K shares | 7.35M | $143.02 | 448.83K |
Q1 2016 | share | Decrease | -11.70% | -55.09K shares | -8.44M | $136.72 | 415.75K |